Sandbox: Langerhans: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 36: Line 36:
:* Recurrent bleeding
:* Recurrent bleeding
:* Recurrent Infections
:* Recurrent Infections
* The infiltration of the hypothalamic pituitary axis by the malignant Langerhans cells will lead to a deficiency in both anterior and posterior pituitary hormones, which may result in:  
* The infiltration of the hypothalamic pituitary axis by malignant Langerhans cells will lead to a deficiency in both anterior and posterior pituitary hormones, which may result in:  
:* Central diabetes insipidus
:* Central diabetes insipidus
:* Growth retardation  
:* Growth retardation  

Revision as of 16:58, 2 February 2016


Overview

Pathogenesis

  • Langerhans cell histiocytosis arises from epidermal dendritic cells, which are normally involved in the process of antigen presentation to lymphocytic cells.
  • Langerhans cells originally arise from the bone marrow, then the cells migrate to other organs such as:
  • Skin
  • Lymph nodes
  • Lungs
  • Hypothalamic pituitary axis
  • Gastrointestinal tract
  • CNS
  • Oral cavity
  • The malignant organ involvement is variable among patients with Langerhans cell histiocytosis. The disease process may range from an isolated cutaneous or bone involvement to a life-threatening multi-system condition.
  • The skeletal distribution of Langerhans cell histiocytosis involves the following sites:
  • The skull (most common bone involved)
  • Ribs
  • Humerus
  • Vertebra
  • The exact pathogenesis of Langerhans cell histiocytosis is not fully understood. It is thought that Langerhans cell histiocytosis is the result of either a true neoplastic process or a reactive immune condition.
  • Facts consistent with the neoplastic process hypothesis include the following:
  • The infiltration of organs by monoclonal population of pathologic cells
  • The presence of specific recurrent cytogenetic and genomic abnormalities
  • The successful treatment of a subset of disseminated Langerhans cell histiocytosis using chemotherapeutic regimens
  • Facts consistent with the reactive immune condition hypothesis include the following:
  • The evidence of spontaneous remissions that may occur among certain cases of Langerhans cell histiocytosis
  • The extensive secretion of multiple cytokines by dendritic cells and bystander-cells (a phenomenon known as cytokine storm)
  • The favorable prognosis and relatively good survival rate among patients with no organ dysfunction
  • The excessive Langerhans cells clonal proliferation will initiate a non-specific inflammatory response, which will lead to the accumulation of various immune system cells such as:
  • Eosinophils
  • Macrophages
  • Lymphocytes
  • Multinucleated giant cells
  • Langerhans cell histiocytosis may result in bone marrow failure due to malignant cell infiltration of the bone marrow. This can manifest as:
  • Anemia
  • Recurrent bleeding
  • Recurrent Infections
  • The infiltration of the hypothalamic pituitary axis by malignant Langerhans cells will lead to a deficiency in both anterior and posterior pituitary hormones, which may result in:
  • Central diabetes insipidus
  • Growth retardation
  • Delayed puberty

Genetics

Associated Conditions

Gross Pathology

Microscopic Pathology